DUBLIN–(BUSINESS WIRE)–The “Glaucoma Surgery Devices – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Glaucoma Surgery Devices estimated at US$1.6 …
Author: Business Wire
GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative dis…
Insights on the Retinal Implants Global Market to 2027 – Featuring Abbott Vascular, Bionic Eye Technologies & Bionic Vision Australia Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Implants – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Retinal Implants estimated at US$39.4 Million in the …
Macular Degeneration Treatment Market – Global Growth, Trends, COVID-19 Impact, and Forecasts 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Macular Degeneration Treatment Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The global macular degeneration treatment market was valued …
Global Ophthalmics Partnering Deal Trends, Players and Financials 2014-2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2014-2021: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmics Partnering 2014-2021 report provides comprehensive access to …
National Vision Holdings, Inc. Announces Participation in the William Blair 41st Annual Growth Stock Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to present at the William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021 at 1:00 p.m. Eastern Time. A live audio w…
Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Virtual Healt…
Guide Dogs for the Blind’s Canine Heroes Virtual Gala to Feature Guide Dog Teams and Costumed “Superpuppies”
SAN RAFAEL, Calif.–(BUSINESS WIRE)– #CanineHeroesVirtualGala–Guide Dogs for the Blind (GDB) will unleash new superpowers at its Canine Heroes Virtual Gala on Sunday, June 6, with heartwarming stories about the power of its guide dog teams, along wit…
Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Gemini Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that Jason Meyenbu…
iHealthScreen Inc. Announces CE Certification for iPredictTM Automated AI System for Early Diagnosis of Diabetic Retinopathy (DR), Age Related Macular degeneration (AMD), and Glaucoma Suspect
NEW YORK–(BUSINESS WIRE)– #AI–iHealthScreen’s AI-based software tool received CE Certification of diabetic retinopathy, macular degeneration, and glaucoma suspect screening.
jCyte Announces Appointment of John Sholar as General Counsel
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a biotech company dedicated to improving the lives of patients with retinal degenerative diseases, today announced the further expansion of the company’s executive management team with the appointmen…
Bollé Safety, the PPE Eyewear Specialists Introduce Go Green: Concrete Actions to Protect the Environment
VILLEURBANNE, France–(BUSINESS WIRE)– #eyewear–Go Green Plan – ESG strategy Highlight of Bollé Safety’s latest sustainable actions.
GenSight Biologics Announces Nature Medicine Case Report Showing Visual Recovery after GS030 Optogenetic Treatment
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative dis…
GenSight Biologics annonce la publication dans Nature Medicine d’un cas de récupération visuelle après traitement optogénétique par GS030
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le tr…
LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chie…
Global Diabetic Macular Edema Epidemiology Forecast to 2030 – Understand the Magnitude of DME Population by its Severity – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema (DME) – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted DME epidemi…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to a new employee as an inducement award outside the Company’s 2017 Equity Incentive Plan in accordance wi…
Global Glaucoma Market to 2030 – Insight, Epidemiology and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma – Market Insight, Epidemiology and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the glaucoma market, historical and …
Heru Series A Funding Accelerates Cloud and Artificial Intelligence-Enabled Wearable Vision Diagnosis and Therapy
MIAMI–(BUSINESS WIRE)–Heru Series A Funding Accelerates Cloud and Artificial Intelligence-Enabled Wearable Vision Diagnosis and Therapy